Complaints re uterine curettes

Question

1. How many complaints has AHPRA received relating to harm caused by uterine curettes since 2022? 2. What action did AHPRA take in response to complaints received? a. Were any of the complainants supported to report their concerns to the TGA?Were any investigations undertaken? b. If so, please advise of the outcome. c. Does AHPRA have guidelines on the threshold for investigation? 3. Was AHPRA consulted on the new patient guidelines for informed consent published by the Commission for Safety and Quality in Health Care? Do you believe that requiring device manufacturers to include information about Asherman's Syndrome in curette packaging is enough to satisfy informed consent to the risks associated with procedures using uterine curettes? If not, what else is required?

Answer

Please find attached answer.

Documents

• Question with answer (PDF) (opens in a new tab)
• Ahpra-2026.009.pdf (opens in a new tab)